0

Close
 
Upcoming Allied Market Research
2023
Neurovascular Stent Market

Neurovascular Stent Market

by Product Type (Carotid artery stents, Intracranial stents), by Material (Metal, Polymer) and by End Users (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A03273
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Neurovascular Stent Market

Request Now !

A neurovascular stent is a small, tube-like, flexible device that is made of either metal or polymer. The device is utilized to treat several conditions in the brain such as stenosis formation in the blood vessels and ischemic stroke. The neurovascular stents are used for thrombectomy as they have the ability to rapidly restore the blood flow in an acute embolic stroke. Globally, ischemic stroke is the major cause of disability and mortality.

High incidence rates of neurovascular disorders and rise in disorders such as ischemic stroke, stenosis, brain aneurysm, and other illnesses are the major driving factors for the market growth. Furthermore, growth in unhealthy diet, excessive alcohol consumption, smoking, less physical activity, and stress has increased the incidence of cerebral aneurysms. In addition, high incidence of blood pressure has increased the risk of suffering from a ruptured aneurysm.

Moreover, a rise in the emergence of neurovascular stents with new technology will drive the market growth during the forecast period. The growing use of nitinol-based neurovascular stents due to its advantages such as superelasticity will help boost the market growth. When compared with other materials such as stainless steel and polymers, nitinol offers excellent biocompatibility, recovering elongation, and visibility.

The global neurovascular stent market is segmented based on product type, material, end users, and geography. Based on product type, the market is bifurcated into carotid artery stents and intracranial stents. Based on material, the market is categorized into metal and polymer. Metal is further divided into stainless steel and nitinol. Based on end users, it is segmented into hospitals, ambulatory surgical centers, and others. Based on geography, the market has been examined across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Abbott Laboratories, Gore Medical, Terumo Medical, Johnson & Johnson, Medtronic, Acandis, Stryker, MicroPort Scientific, Cordis, and MicroPort Scientific have also been provided in this report.

Key Benefits

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global market.
  • This report entails a detailed quantitative analysis of the current market and estimations which assists in identifying prevailing market opportunities.
  • The projections in this report are made by analyzing the current trends and future market potential in terms of value.
  • Competitive intelligence (of leading manufacturers and distributors of neurovascular stents) helps understand the competitive scenario globally.
  • An in-depth analysis of current research and clinical developments within the market has been provided with key market dynamic factors that help understand the behavior of the market.

 Neurovascular Stent Market Report Highlights

Aspects Details
By Product Type
  • Carotid artery stents
  • Intracranial stents
By Material
  • Metal
    • Stainless steel
    • Nitinol
  • Polymer
By End Users
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Abbott Laboratories, Acandis, Stryker, MicroPort Scientific, Boston Scientific Corporation, Medtronic, Cordis, Terumo Medical, Johnson & Johnson, Gore Medical
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: NEUROVASCULAR STENT MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Carotid Artery Stents

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Intracranial Stents

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: NEUROVASCULAR STENT MARKET, BY MATERIAL

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Material

    • 5.2. Metal

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

      • 5.2.4. Stainless steel

        • 5.2.4.1. Market Size and Forecast

      • 5.2.4. Nitinol

        • 5.2.4.1. Market Size and Forecast

    • 5.3. Polymer

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: NEUROVASCULAR STENT MARKET, BY END USERS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End Users

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Surgical Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Others

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: NEUROVASCULAR STENT MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product Type

      • 7.2.3. Market Size and Forecast, By Material

      • 7.2.4. Market Size and Forecast, By End Users

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Neurovascular Stent Market

        • 7.2.6.1. Market Size and Forecast, By Product Type
        • 7.2.6.2. Market Size and Forecast, By Material
        • 7.2.6.3. Market Size and Forecast, By End Users

      • 7.2.7. Canada Neurovascular Stent Market

        • 7.2.7.1. Market Size and Forecast, By Product Type
        • 7.2.7.2. Market Size and Forecast, By Material
        • 7.2.7.3. Market Size and Forecast, By End Users

      • 7.2.8. Mexico Neurovascular Stent Market

        • 7.2.8.1. Market Size and Forecast, By Product Type
        • 7.2.8.2. Market Size and Forecast, By Material
        • 7.2.8.3. Market Size and Forecast, By End Users

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product Type

      • 7.3.3. Market Size and Forecast, By Material

      • 7.3.4. Market Size and Forecast, By End Users

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Neurovascular Stent Market

        • 7.3.6.1. Market Size and Forecast, By Product Type
        • 7.3.6.2. Market Size and Forecast, By Material
        • 7.3.6.3. Market Size and Forecast, By End Users

      • 7.3.7. Germany Neurovascular Stent Market

        • 7.3.7.1. Market Size and Forecast, By Product Type
        • 7.3.7.2. Market Size and Forecast, By Material
        • 7.3.7.3. Market Size and Forecast, By End Users

      • 7.3.8. Italy Neurovascular Stent Market

        • 7.3.8.1. Market Size and Forecast, By Product Type
        • 7.3.8.2. Market Size and Forecast, By Material
        • 7.3.8.3. Market Size and Forecast, By End Users

      • 7.3.9. Spain Neurovascular Stent Market

        • 7.3.9.1. Market Size and Forecast, By Product Type
        • 7.3.9.2. Market Size and Forecast, By Material
        • 7.3.9.3. Market Size and Forecast, By End Users

      • 7.3.10. UK Neurovascular Stent Market

        • 7.3.10.1. Market Size and Forecast, By Product Type
        • 7.3.10.2. Market Size and Forecast, By Material
        • 7.3.10.3. Market Size and Forecast, By End Users

      • 7.3.11. Russia Neurovascular Stent Market

        • 7.3.11.1. Market Size and Forecast, By Product Type
        • 7.3.11.2. Market Size and Forecast, By Material
        • 7.3.11.3. Market Size and Forecast, By End Users

      • 7.3.12. Rest Of Europe Neurovascular Stent Market

        • 7.3.12.1. Market Size and Forecast, By Product Type
        • 7.3.12.2. Market Size and Forecast, By Material
        • 7.3.12.3. Market Size and Forecast, By End Users

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product Type

      • 7.4.3. Market Size and Forecast, By Material

      • 7.4.4. Market Size and Forecast, By End Users

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Neurovascular Stent Market

        • 7.4.6.1. Market Size and Forecast, By Product Type
        • 7.4.6.2. Market Size and Forecast, By Material
        • 7.4.6.3. Market Size and Forecast, By End Users

      • 7.4.7. Japan Neurovascular Stent Market

        • 7.4.7.1. Market Size and Forecast, By Product Type
        • 7.4.7.2. Market Size and Forecast, By Material
        • 7.4.7.3. Market Size and Forecast, By End Users

      • 7.4.8. India Neurovascular Stent Market

        • 7.4.8.1. Market Size and Forecast, By Product Type
        • 7.4.8.2. Market Size and Forecast, By Material
        • 7.4.8.3. Market Size and Forecast, By End Users

      • 7.4.9. South Korea Neurovascular Stent Market

        • 7.4.9.1. Market Size and Forecast, By Product Type
        • 7.4.9.2. Market Size and Forecast, By Material
        • 7.4.9.3. Market Size and Forecast, By End Users

      • 7.4.10. Australia Neurovascular Stent Market

        • 7.4.10.1. Market Size and Forecast, By Product Type
        • 7.4.10.2. Market Size and Forecast, By Material
        • 7.4.10.3. Market Size and Forecast, By End Users

      • 7.4.11. Thailand Neurovascular Stent Market

        • 7.4.11.1. Market Size and Forecast, By Product Type
        • 7.4.11.2. Market Size and Forecast, By Material
        • 7.4.11.3. Market Size and Forecast, By End Users

      • 7.4.12. Malaysia Neurovascular Stent Market

        • 7.4.12.1. Market Size and Forecast, By Product Type
        • 7.4.12.2. Market Size and Forecast, By Material
        • 7.4.12.3. Market Size and Forecast, By End Users

      • 7.4.13. Indonesia Neurovascular Stent Market

        • 7.4.13.1. Market Size and Forecast, By Product Type
        • 7.4.13.2. Market Size and Forecast, By Material
        • 7.4.13.3. Market Size and Forecast, By End Users

      • 7.4.14. Rest of Asia Pacific Neurovascular Stent Market

        • 7.4.14.1. Market Size and Forecast, By Product Type
        • 7.4.14.2. Market Size and Forecast, By Material
        • 7.4.14.3. Market Size and Forecast, By End Users

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product Type

      • 7.5.3. Market Size and Forecast, By Material

      • 7.5.4. Market Size and Forecast, By End Users

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Neurovascular Stent Market

        • 7.5.6.1. Market Size and Forecast, By Product Type
        • 7.5.6.2. Market Size and Forecast, By Material
        • 7.5.6.3. Market Size and Forecast, By End Users

      • 7.5.7. South Africa Neurovascular Stent Market

        • 7.5.7.1. Market Size and Forecast, By Product Type
        • 7.5.7.2. Market Size and Forecast, By Material
        • 7.5.7.3. Market Size and Forecast, By End Users

      • 7.5.8. Saudi Arabia Neurovascular Stent Market

        • 7.5.8.1. Market Size and Forecast, By Product Type
        • 7.5.8.2. Market Size and Forecast, By Material
        • 7.5.8.3. Market Size and Forecast, By End Users

      • 7.5.9. UAE Neurovascular Stent Market

        • 7.5.9.1. Market Size and Forecast, By Product Type
        • 7.5.9.2. Market Size and Forecast, By Material
        • 7.5.9.3. Market Size and Forecast, By End Users

      • 7.5.10. Argentina Neurovascular Stent Market

        • 7.5.10.1. Market Size and Forecast, By Product Type
        • 7.5.10.2. Market Size and Forecast, By Material
        • 7.5.10.3. Market Size and Forecast, By End Users

      • 7.5.11. Rest of LAMEA Neurovascular Stent Market

        • 7.5.11.1. Market Size and Forecast, By Product Type
        • 7.5.11.2. Market Size and Forecast, By Material
        • 7.5.11.3. Market Size and Forecast, By End Users

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Abbott Laboratories

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Gore Medical

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Terumo Medical

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Johnson And Johnson

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Medtronic

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Acandis

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Stryker

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. MicroPort Scientific

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Cordis

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Boston Scientific Corporation

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEUROVASCULAR STENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL NEUROVASCULAR STENT MARKET FOR CAROTID ARTERY STENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL NEUROVASCULAR STENT MARKET FOR INTRACRANIAL STENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR STENT MARKET, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR STENT MARKET FOR METAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL NEUROVASCULAR STENT MARKET FOR POLYMER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL NEUROVASCULAR STENT MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR STENT MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR STENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR STENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR STENT MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA NEUROVASCULAR STENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 16. U.S. NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 17. U.S. NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 18. U.S. NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 19. CANADA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 20. CANADA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 21. CANADA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 22. MEXICO NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 25. EUROPE NEUROVASCULAR STENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 29. FRANCE NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. FRANCE NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 31. FRANCE NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 35. ITALY NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 36. ITALY NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 37. ITALY NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 38. SPAIN NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 39. SPAIN NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 40. SPAIN NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 41. UK NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 42. UK NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 43. UK NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 44. RUSSIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 45. RUSSIA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 46. RUSSIA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC NEUROVASCULAR STENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 54. CHINA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 55. CHINA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 56. CHINA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 59. JAPAN NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 60. INDIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 61. INDIA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 62. INDIA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH KOREA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 68. AUSTRALIA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 69. THAILAND NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 70. THAILAND NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 71. THAILAND NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 72. MALAYSIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 73. MALAYSIA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 74. MALAYSIA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 75. INDONESIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 76. INDONESIA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 77. INDONESIA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 78. REST OF ASIA PACIFIC NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 81. LAMEA NEUROVASCULAR STENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 82. LAMEA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 83. LAMEA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 84. LAMEA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 85. BRAZIL NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 86. BRAZIL NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 87. BRAZIL NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH AFRICA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH AFRICA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH AFRICA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 91. SAUDI ARABIA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 92. SAUDI ARABIA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 93. SAUDI ARABIA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 94. UAE NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 95. UAE NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 96. UAE NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 97. ARGENTINA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 98. ARGENTINA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 99. ARGENTINA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 100. REST OF LAMEA NEUROVASCULAR STENT, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 101. REST OF LAMEA NEUROVASCULAR STENT, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 102. REST OF LAMEA NEUROVASCULAR STENT, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 103. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 104. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 105. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 106. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 107. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. GORE MEDICAL: KEY EXECUTIVES
  • TABLE 109. GORE MEDICAL: COMPANY SNAPSHOT
  • TABLE 110. GORE MEDICAL: OPERATING SEGMENTS
  • TABLE 111. GORE MEDICAL: PRODUCT PORTFOLIO
  • TABLE 112. GORE MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. TERUMO MEDICAL: KEY EXECUTIVES
  • TABLE 114. TERUMO MEDICAL: COMPANY SNAPSHOT
  • TABLE 115. TERUMO MEDICAL: OPERATING SEGMENTS
  • TABLE 116. TERUMO MEDICAL: PRODUCT PORTFOLIO
  • TABLE 117. TERUMO MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 119. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 120. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 121. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 122. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. MEDTRONIC: KEY EXECUTIVES
  • TABLE 124. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 125. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 126. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 127. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. ACANDIS: KEY EXECUTIVES
  • TABLE 129. ACANDIS: COMPANY SNAPSHOT
  • TABLE 130. ACANDIS: OPERATING SEGMENTS
  • TABLE 131. ACANDIS: PRODUCT PORTFOLIO
  • TABLE 132. ACANDIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. STRYKER: KEY EXECUTIVES
  • TABLE 134. STRYKER: COMPANY SNAPSHOT
  • TABLE 135. STRYKER: OPERATING SEGMENTS
  • TABLE 136. STRYKER: PRODUCT PORTFOLIO
  • TABLE 137. STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. MICROPORT SCIENTIFIC: KEY EXECUTIVES
  • TABLE 139. MICROPORT SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 140. MICROPORT SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 141. MICROPORT SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 142. MICROPORT SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. CORDIS: KEY EXECUTIVES
  • TABLE 144. CORDIS: COMPANY SNAPSHOT
  • TABLE 145. CORDIS: OPERATING SEGMENTS
  • TABLE 146. CORDIS: PRODUCT PORTFOLIO
  • TABLE 147. CORDIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 149. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 150. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 151. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 152. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROVASCULAR STENT MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEUROVASCULAR STENT MARKET
  • FIGURE 3. SEGMENTATION NEUROVASCULAR STENT MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEUROVASCULAR STENT MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEUROVASCULAR STENT MARKET
  • FIGURE 11. NEUROVASCULAR STENT MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. NEUROVASCULAR STENT MARKET FOR CAROTID ARTERY STENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. NEUROVASCULAR STENT MARKET FOR INTRACRANIAL STENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. NEUROVASCULAR STENT MARKET SEGMENTATION, BY BY MATERIAL
  • FIGURE 15. NEUROVASCULAR STENT MARKET FOR METAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. NEUROVASCULAR STENT MARKET FOR POLYMER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. NEUROVASCULAR STENT MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 18. NEUROVASCULAR STENT MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. NEUROVASCULAR STENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. NEUROVASCULAR STENT MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 25. COMPETITIVE DASHBOARD
  • FIGURE 26. COMPETITIVE HEATMAP: NEUROVASCULAR STENT MARKET
  • FIGURE 27. Top player positioning, 2022
  • FIGURE 28. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 29. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 30. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 31. GORE MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. GORE MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. GORE MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. TERUMO MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. TERUMO MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. TERUMO MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. JOHNSON AND JOHNSON: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. MEDTRONIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. MEDTRONIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. ACANDIS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. ACANDIS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. ACANDIS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. STRYKER: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. STRYKER: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. STRYKER: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. MICROPORT SCIENTIFIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. MICROPORT SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. MICROPORT SCIENTIFIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. CORDIS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. CORDIS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. CORDIS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Neurovascular Stent Market

Start reading.
This Report and over 68,113+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers